Categoria 2 research hub

Omalizumab for monotherapy treatment of patients with food allergies to plant-based foods due to sensitization to LTP and profilin

This study is looking at a medicine called omalizumab to see if it can help people with severe allergies to certain plant-based foods, like peaches and melons. It focuses on those who haven't improved with other treatments, aiming to see if they can eat more of these foods safely after taking the medicine.